"Feb. 22, 2011 -- The FDA has issued a safety announcement notifying health care professionals that it has updated the pregnancy section of drug labels for the entire class of antipsychotic medications.
Antipsychotic drugs are used to "...
- Patient Information:
Details with Side Effects
MOBAN (molindone hydrochloride tablets) has a pharmacological profile in laboratory animals which predominantly resembles that of other antipsychotic agents causing reduction of spontaneous locomotion and aggressiveness, suppression of a conditioned response and antagonism of the bizarre stereotyped behavior and hyperactivity induced by amphetamines. In addition, MOBAN (molindone hydrochloride tablets) antagonizes the depression caused by the tranquilizing agent tetrabenazine.
In human clinical studies an antipsychotic effect is achieved in the absence of muscle relaxing or incoordinating effects. Based on EEG studies, MOBAN (molindone hydrochloride tablets) exerts its effect on the ascending reticular activating system.
Human metabolic studies show MOBAN (molindone hydrochloride tablets) to be rapidly absorbed and metabolized when given orally. Unmetabolized drug reached a peak blood level at 1.5 hours. Pharmacological effect from a single oral dose persists for 24-36 hours. There are 36 recognized metabolites with less than 23% unmetabolized MOBAN (molindone hydrochloride tablets) being excreted in urine and feces.
Last reviewed on RxList: 1/13/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Moban Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get tips on therapy and treatment.